Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 211929 / DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 6MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| Budesonide(UNII: Q3OKS62Q6X) (Budesonide - UNII:Q3OKS62Q6X) | Budesonide | 9mg | 6mg |
Inactive Ingredients
| Ingredient Name | Ferring Pharmaceuticals Inc. |
|---|---|
| Acetyltributyl Citrate(0ZBX0N59RZ) | |
| Dimethicone(92RU3N3Y1O) | |
| Ethylcellulose, Unspecified(7Z8S9VYZ4B) | |
| Ferric Oxide Red(1K09F3G675) | |
| Ferric Oxide Yellow(EX438O2MRT) | |
| Ferrosoferric Oxide(XM0M87F357) | |
| Gelatin, Unspecified(2G86QN327L) | |
| METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER(NX76LV5T8J) | |
| Polysorbate 80(6OZP39ZG8H) | |
| Potassium Hydroxide(WZH3C48M4T) | |
| Shellac(46N107B71O) | |
| Sodium Lauryl Sulfate(368GB5141J) | |
| Starch, Corn(O8232NY3SJ) | |
| Sucrose(C151H8M554) | |
| Talc(7SEV7J4R1U) | |
| Titanium Dioxide(15FIX9V2JP) | |
| Triethyl Citrate(8Z96QXD6UM) |
